Home › Compare › MDAV vs EQR

MDAV vs EQR: Dividend Comparison 2026

MDAV yields 1000000.00% · EQR yields 5.87%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MDAV wins by $4.7683925249533696e+36M in total portfolio value
10 years
MDAV
MDAV
● Live price
1000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.7683925249533696e+36M
Annual income
$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00
Full MDAV calculator →
EQR
EQR
● Live price
5.87%
Share price
$59.15
Annual div
$3.47
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47.8K
Annual income
$5,475.61
Full EQR calculator →

Portfolio growth — MDAV vs EQR

📍 MDAV pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMDAVEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MDAV + EQR cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
MDAV pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MDAV
Annual income on $10K today (after 15% tax)
$85,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$4,052,336,490,287,657,000,000,000,000,000,000,000,000,000.00/yr
EQR
Annual income on $10K today (after 15% tax)
$499.01/yr
After 10yr DRIP, annual income (after tax)
$4,654.27/yr
At 15% tax rate, MDAV beats the other by $4,052,336,490,287,657,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MDAV + EQR for your $10,000?

MDAV: 50%EQR: 50%
100% EQR50/50100% MDAV
Portfolio after 10yr
$2.3841962624766848e+36M
Annual income
$2,383,727,347,228,033,600,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.98%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

MDAV
No analyst data
Altman Z
-6.3
Piotroski
1/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+18.9% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MDAV buys
0
EQR buys
0
No recent congressional trades found for MDAV or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMDAVEQR
Forward yield1000000.00% ✓5.87%
Annual dividend / share$2.00$3.47 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8% ✓
Portfolio after 10y$4.7683925249533696e+36M$47.8K ✓
Annual income after 10y$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00 ✓$5,475.61
Total dividends collected$4.7683311610149396e+36M$23.0K ✓
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: MDAV vs EQR ($10,000, DRIP)

YearMDAV PortfolioMDAV Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$100,010,700$100,000,000.00$11,380$679.82+$100.00M → MDAV
2$934,786,450,701$934,679,439,252.34$13,014$837.25+$934786.44M → MDAV
3$8,165,787,108,578,292$8,164,786,887,076,042.00$14,961$1,036.20+$8165787108.56M → MDAV
4$66,665,884,190,957,650,000$66,657,146,798,751,470,000.00$17,297$1,289.22+$66665884190957.63M → MDAV
5$508,662,171,058,048,100,000,000$508,590,838,561,963,700,000,000.00$20,121$1,613.15+$508662171058048128.00M → MDAV
6$3,627,235,248,428,489,700,000,000,000$3,626,690,979,905,457,600,000,000,000.00$23,561$2,030.84+$3.62723524842849e+21M → MDAV
7$24,173,681,159,150,610,000,000,000,000,000$24,169,800,017,434,790,000,000,000,000,000.00$27,783$2,573.54+$2.417368115915061e+25M → MDAV
8$150,567,402,861,454,640,000,000,000,000,000,000$150,541,537,022,614,370,000,000,000,000,000,000.00$33,013$3,284.39+$1.5056740286145463e+29M → MDAV
9$876,477,100,281,847,600,000,000,000,000,000,000,000$876,315,993,160,785,800,000,000,000,000,000,000,000.00$39,547$4,223.51+$8.764771002818475e+32M → MDAV
10$4,768,392,524,953,369,600,000,000,000,000,000,000,000,000$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00$47,791$5,475.61+$4.7683925249533696e+36M → MDAV

MDAV vs EQR: Complete Analysis 2026

MDAV — Stock

Davi Luxury Brand Group, Inc. develops and markets a line of skin care/cosmetic products based on grape and botanical-based luxury branded skin care products for women and men under the Davi, Davi Skin, and Davi Napa brand names. The company offers skin care, cosmetics, hair care, and other products. It provides approximately 30 Davi branded products of which approximately 20 are sold through its daviskin.com Website. The company's target customers include retail stores, luxury hotels, and in-flight and duty-free shops. The company was formerly known as Dafoe Corp. and changed its name to Davi Luxury Brand Group, Inc. in January 2011. Davi Luxury Brand Group, Inc. was founded in 2007 and is headquartered in Beverly Hills, California.

Full MDAV Calculator →

EQR — REIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this MDAV vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MDAV vs SCHDMDAV vs JEPIMDAV vs OMDAV vs KOMDAV vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.